GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $245,000 | -7.5% | 6,497 | 0.0% | 0.10% | -18.6% |
Q2 2020 | $265,000 | +8.6% | 6,497 | +0.7% | 0.12% | -13.2% |
Q1 2020 | $244,000 | -19.7% | 6,452 | -0.2% | 0.14% | +5.4% |
Q4 2019 | $304,000 | +10.5% | 6,463 | +0.5% | 0.13% | +6.6% |
Q3 2019 | $275,000 | +5.4% | 6,433 | -1.3% | 0.12% | +0.8% |
Q2 2019 | $261,000 | -4.0% | 6,516 | -0.0% | 0.12% | -9.1% |
Q1 2019 | $272,000 | +8.4% | 6,519 | -0.7% | 0.13% | -13.2% |
Q4 2018 | $251,000 | – | 6,563 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |